TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Karo Pharma AS
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 452,630 | 375,975 | 287,880 |
Financial expenses | 6,538 | 3,648 | 3,617 |
Earnings before taxes | 89,154 | 104,342 | 76,199 |
Total assets | 269,199 | 282,236 | 199,781 |
Current assets | 239,024 | 247,487 | 159,610 |
Current liabilities | 164,442 | 166,215 | 105,112 |
Equity capital | 104,756 | 113,886 | 92,800 |
- share capital | 4,802 | 5,069 | 4,809 |
Employees (average) | 22 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 38.9% | 40.4% | 46.5% |
Turnover per employee | 13,085 | ||
Profit as a percentage of turnover | 19.7% | 27.8% | 26.5% |
Return on assets (ROA) | 35.5% | 38.3% | 40.0% |
Current ratio | 145.4% | 148.9% | 151.8% |
Return on equity (ROE) | 85.1% | 91.6% | 82.1% |
Change turnover | 96,403 | 72,583 | -25,571 |
Change turnover % | 27% | 24% | -8% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.